Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (286)	9/25/2000 9:13:40 PM
From: BulbaMan	Read Replies (1) \| Respond to of 1833

Give me a break, Rick. Let's say I knew someone at the Vogelstein-Kinzler oncology lab and told them I had read the SMDX press release and was wondering what they thought of the company's equipment the lab just installed. What's wrong with that? In fact, I don't see why it would be tacky to just call the lab asking to speak with someone familiar with the equipment and get their opinion – being, of course, honest and telling them you're investigating SMDX as a potential investment. I might add, that a couple of years ago I called a reporter to ask about a product (not biotech related) she had done a story on. She didn't know the company involved had a listed stock and was grateful to get that info from me. OK, maybe bothering Vogelstein would be too presumptuous and perhaps I'm being a leech by hoping others will do the work (my thinking was I'm not knowledgeable enough to ask the right questions). But I don't see how checking out a product with users for investment purposes is at all tacky. Other posters comments on this issue are welcome.